Key Account Director - Northern Plaines at Acadia Pharmaceuticals

Chicago, Illinois, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, HealthcareIndustries

Requirements

Bachelor’s degree required
Proven track record of 12 or more years of successful account management in the biotech or pharmaceutical industry
Extensive customer relationships with key account RX and Medical Directors
Demonstrated ability to consistently meet or exceed quantitative and qualitative targets
Ability to travel 60-80%
Strong project management experience with superior analytical and planning skills
Effective team player, capable of thriving in a dynamic, cross-functional environment
Excellent written, organizational, and verbal communication skills
Proficient in MS Office products including PowerPoint, Word, Access, and Excel
Reside within the geographic area of responsibility to facilitate efficient account management
A valid driver’s license is required due to the essential duty of driving

Responsibilities

Represent Madrigal with Integrated Delivery Systems and large HCP Super Groups, engaging with C-suite executives, pharmacy directors, and medical directors within the assigned accounts
Articulate compelling unbranded and branded messaging within PI labeling including the Brand Value Propositions, brand clinical information (approved reprints) and approved Health Economic Data and Models
Drive customer engagement by providing deep insights and expertise around the MAFLD/MASH disease continuum, offering valuable customer insights on trends, market conditions, protocol development, and changes in formulary/medical policies
Leverage and champion core key account resources and sales planning tools to optimize sales performance
Encourage and facilitate MML/HEOR/Marketing team interactions with customers, foster consultation and collaboration with stakeholders across matrixed organizations to develop patient-centric solutions, unique MML engagements and relationship building with peers
Collaborate with functional matrix team leaders to optimize business performance and/or effectively manage complex business risks and issues
Develop and execute Key Account matrix business plans in cooperation with cross functional leaders (Sales, Medical Affairs, Marketing, Market Access & Patient Support)
Ensure all activities are conducted in strict compliance with all applicable local, state and federal laws and regulations as well as company policies

Skills

Key Account Management

Stakeholder Engagement

C-Suite Interaction

HEOR

Market Access

Pharmaceutical Sales

Disease State Expertise

Formulary Management

Sales Planning

Value Proposition Development

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free